Livzon Pharmaceutical Group (HKG:1513) said Chinese regulators accepted its marketing authorization application for the lecankitug injection jointly developed with Beijing Xinkanghe Biopharmaceutical Technology, according to a Monday filing with the Hong Kong bourse.
The medicine is aimed at treating adult patients with active ankylosing spondylitis, a chronic inflammatory rheumatic and immune-mediated disease.
Stride Property Group (NZE:SPG) said that Chair Tim Storey has resigned, effective immediately, as part of his planned retirement ahead of the upcoming annual shareholder meetings, according to a Tuesday filing with the New Zealand bourse.David Green has been appointed as independent chair of the board, effective Tuesday, the filing added.The company's shares fell 1% in recent Tuesday trade.
Australian Finance Group (ASX:AFG) launched an on-market share buy-back program of up to AU$15 million, according to a Tuesday filing with the Australian bourse.The company plans to start the buy-back from June 16 for up to six months, ending on Dec. 15, unless terminated or completed earlier, the filing said.The maximum number of shares that may be acquired under the buy-back is roughly 9.7 million, representing about 3.5% of the company's current issued capital, per the filing.Shares fell 5% in morning trade on Tuesday and earlier reached their lowest since July 2024.
Vector (NZE:VCT) decided to retain ownership of its Fibre business following a strategic review, according to a Tuesday New Zealand bourse filing.Vector Fibre will continue delivering to its customers and pursuing growth opportunities, including through data center and 5G expansion in Auckland, the company added.The company's shares fell 1% in recent Tuesday trade.